Last edition
News about "ADC platform technology"
Asahi Kasei Life Science Acquires License for Novel ADC Technology from The Noguchi Institute
Asahi Kasei Life Science Secures Rights to Novel Antibody Drug Conjugate (ADC) Technology from The Noguchi Institute to Advance Safer and More Efficient Cancer Therapies
ADC Platform Technology | 28/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members